Literature DB >> 4373589

Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism.

R J Santen, A Lipton, J Kendall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4373589

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  23 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 2.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

3.  On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.

Authors:  E Petru; D Schmähl
Journal:  Klin Wochenschr       Date:  1987-10-15

4.  Aminoglutethimide-induced myelosuppression.

Authors:  J T van der Heijden; T A Splinter
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  Aminoglutethimide and warfarin. A new important drug interaction.

Authors:  P E Lønning; S Kvinnsland; G Jahren
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  Single-dose and steady-state pharmacokinetics of aminoglutethimide.

Authors:  P E Lønning; J S Schanche; S Kvinnsland; P M Ueland
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

Review 7.  Could aminoglutethimide replace adrenalectomy?

Authors:  A L Harris
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

8.  The absolute configuration of the enantiomers of glutethimide and aminoglutethimide.

Authors:  N Finch; R Dziemian; J Cohen; B G Steinetz
Journal:  Experientia       Date:  1975-09-15

9.  Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.

Authors:  B P Haynes; M Jarman; M Dowsett; A Mehta; P E Lønning; L J Griggs; A Jones; T Powles; R Stein; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 10.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.